Lymphatics in the liver
Lymphatics in the liver
批准号:
10391056
负责人:
YASUKO IWAKIRI
金额:
$62.17万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-07-01 至 2027-06-30
关键词:
3-DimensionalAblationAreaAscitesCarbon TetrachlorideCellsCirrhosisDataDevelopmentDiseaseDisease ProgressionFatty acid glycerol estersFibronectinsFluid BalanceFluorescence MicroscopyFunctional disorderGoalsHealthHepaticHepatic FibrogenesisHepatocyteImmunologic SurveillanceInflammationInflammatory ResponseInhalationIntegrinsKDR geneKupffer CellsLigationLightLiverLiver FibrosisLymphLymphangiogenesisLymphaticLymphatic Endothelial CellsLymphatic SystemModelingMusNerveNervous system structureNeurotransmittersOperative Surgical ProceduresOrganPatientsPhenotypePhysiologyPlayPortal HypertensionPortal vein structurePreventionPreventive treatmentProductionRegulationResearchRoleSchwann CellsSignal TransductionSiteSourceSurgical ModelsTestingTherapeuticTissuesVascular Endothelial Growth Factor CVascular Endothelial Growth Factor Receptor-3absorptionbile ductliver developmentlymphatic vesselmacrophageoverexpressionrecruitresponsesingle-cell RNA sequencingspatiotemporaltreatment effectvascular contributionsvessel regression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SUMMARY
The lymphatic system maintains tissue fluid homeostasis and regulates local inflammatory
responses.1,2 The liver lymphatic system remains poorly understood. The goal of this proposed research is to
advance our understanding of the mechanisms of hepatic lymphangiogenesis (the formation of new lymphatic
vessels) and the role of lymphatic vessels in liver pathophysiology.
Vascular endothelial growth factor C (VEGF-C) is the major inducer of lymphangiogenesis. Our
preliminary studies have shown that enhanced hepatic lymphangiogenesis by VEGF-C overexpression
reduces liver fibrosis, suggesting a therapeutic potential. Additional data show that Schwann cells of hepatic
sympathetic nerves play a central role in hepatic lymphangiogenesis as a source of VEGF-C and as a recruiter
of macrophages, which may contribute to hepatic lymphangiogenesis by producing fibronectin-1 (FN1), a
substrate for integrins essential for VEGF-C/VEGF receptor 3 (VEGFR3) signaling. We thus hypothesize that
lymphatic ablation should increase inflammation and promote disease progression, and lymphangiogenesis
driven by Schwann cells and macrophages through VEGF-C signaling should alleviate inflammation and inhibit
disease progression. To test these hypotheses, we propose the following Specific Aims:
1. Determine the Schwann cell-driven mechanisms that promote hepatic lymphangiogenesis.
2. Determine Kupffer cells/macrophages-driven mechanisms that promote hepatic lymphangiogenesis.
3. Determine the role of lymphangiogenesis in the development of liver fibrosis.
The proposed research will elucidate the regulation of lymphatic vessels visually and mechanistically
and their functional importance in liver fibrosis/cirrhosis. Further, the potential of VEGF-C overexpression and
subsequent induction of lymphangiogenesis for the prevention and treatment of liver fibrosis/cirrhosis as well
as portal hypertension and ascites will be evaluated. Furthermore, this research will significantly contribute to
the advancement of the study of the liver by exploring relatively underexamined areas of the hepatic lymphatic
system and nervous system.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hepatic lymphatics in alcohol-associated liver disease
-
批准号:10824029
-
项目类别:
-
资助金额:$21.16万
-
财政年份:2023
-
负责人:YASUKO IWAKIRI
-
依托单位:
Lymphatics in the liver
-
批准号:10657334
-
项目类别:
-
资助金额:$58.93万
-
财政年份:2022
-
负责人:YASUKO IWAKIRI
-
依托单位:
Endotheliopathy and liver injury in COVID-19
-
批准号:10468220
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2021
-
负责人:YASUKO IWAKIRI
-
依托单位:
Endotheliopathy and liver injury in COVID-19
-
批准号:10662455
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2021
-
负责人:YASUKO IWAKIRI
-
依托单位:
Endotheliopathy and liver injury in COVID-19
-
批准号:10319358
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2021
-
负责人:YASUKO IWAKIRI
-
依托单位:
Hemodynamics and hepatic remodeling
-
批准号:9920142
-
项目类别:
-
资助金额:$37.69万
-
财政年份:2018
-
负责人:YASUKO IWAKIRI
-
依托单位:
Hemodynamics and hepatic remodeling
-
批准号:9542958
-
项目类别:
-
资助金额:$37.69万
-
财政年份:2018
-
负责人:YASUKO IWAKIRI
-
依托单位:
The role of Kupffer cells in alcohol-induced liver disease
-
批准号:9761401
-
项目类别:
-
资助金额:$37.62万
-
财政年份:2017
-
负责人:YASUKO IWAKIRI
-
依托单位:
Mechanisms of Alcohol-Induced Hepatic Osteodystrophy
-
批准号:8969937
-
项目类别:
-
资助金额:$24.08万
-
财政年份:2016
-
负责人:YASUKO IWAKIRI
-
依托单位:
Mechanisms of Alcohol-Induced Hepatic Osteodystrophy
-
批准号:9326892
-
项目类别:
-
资助金额:$19.89万
-
财政年份:2016
-
负责人:YASUKO IWAKIRI
-
依托单位:
Alcohol metabolism in liver sinusoidal endothelial cells
-
批准号:9116749
-
项目类别:
-
资助金额:$19.77万
-
财政年份:2015
-
负责人:YASUKO IWAKIRI
-
依托单位:
Alcohol metabolism in liver sinusoidal endothelial cells
-
批准号:8965570
-
项目类别:
-
资助金额:$23.93万
-
财政年份:2015
-
负责人:YASUKO IWAKIRI
-
依托单位:
Arterial Remodeling in Chronic Liver Diseases
-
批准号:8286394
-
项目类别:
-
资助金额:$35.28万
-
财政年份:2009
-
负责人:YASUKO IWAKIRI
-
依托单位:
Arterial Remodeling in Chronic Liver Diseases
-
批准号:8500246
-
项目类别:
-
资助金额:$34.05万
-
财政年份:2009
-
负责人:YASUKO IWAKIRI
-
依托单位:
Arterial Remodeling in Chronic Liver Diseases
-
批准号:7729752
-
项目类别:
-
资助金额:$38.64万
-
财政年份:2009
-
负责人:YASUKO IWAKIRI
-
依托单位:
Arterial Remodeling in Chronic Liver Diseases
-
批准号:8587675
-
项目类别:
-
资助金额:$0.15万
-
财政年份:2009
-
负责人:YASUKO IWAKIRI
-
依托单位:
Arterial Remodeling in Chronic Liver Diseases
-
批准号:8085781
-
项目类别:
-
资助金额:$35.28万
-
财政年份:2009
-
负责人:YASUKO IWAKIRI
-
依托单位:
Arterial Remodeling in Chronic Liver Diseases
-
批准号:8724090
-
项目类别:
-
资助金额:$8.85万
-
财政年份:2009
-
负责人:YASUKO IWAKIRI
-
依托单位:
Arterial Remodeling in Chronic Liver Diseases
-
批准号:8913298
-
项目类别:
-
资助金额:$6.1万
-
财政年份:2009
-
负责人:YASUKO IWAKIRI
-
依托单位:
Arterial Remodeling in Chronic Liver Diseases
-
批准号:7848984
-
项目类别:
-
资助金额:$39.32万
-
财政年份:2009
-
负责人:YASUKO IWAKIRI
-
依托单位:
海外基金